
Feverin100 mg
General Pharmaceuticals Ltd.
Nimesulide is a non-steroidal anti-inflammatory drug (NSAID) that preferentially inhibits the COX-2 enzyme.
Nimesulide is a non-steroidal anti-inflammatory drug (NSAID) that preferentially inhibits the COX-2 enzyme. Its use varies significantly by country because several major regulators have restricted or never approved it due to hepatotoxicity concerns.
Nimesulide is not approved in the United States, United Kingdom, Canada, Australia, and several other markets. In the European Union and a number of Asian countries it remains available but under tightened restrictions (adult-only, short-course use, prescription-only, with hepatic-injury warnings) following safety reviews. Where Nimesulide is available, it should only be used for the shortest duration and lowest effective dose needed, and is not intended for chronic/long-term use.
| Indication | Adult dose | Notes |
|---|---|---|
| Acute musculoskeletal pain / sprains | 100 mg twice daily, after meals | Maximum treatment duration generally 15 days; use lowest effective dose for the shortest time |
| Primary dysmenorrhea | 100 mg twice daily, started at onset of symptoms | Limit to the treatment period needed for the menstrual episode |
| Post-operative/post-traumatic pain (adjunct) | 100 mg twice daily, after meals | Short-term adjunct only; reassess if pain persists beyond a few days |
Nimesulide is contraindicated in children under 12 years in most markets where it is available (see Contraindications and Use in Special Populations). It is not recommended for pediatric use where safety has not been separately established.
Nimesulide is contraindicated in patients with hepatic impairment or a history of hepatotoxicity with Nimesulide (see Contraindications). Use with caution and at the lowest effective dose in mild renal impairment; avoid in significant renal impairment (see Precautions and Warnings).
| Frequency | Effects |
|---|---|
| Common | Diarrhea, nausea, vomiting, dizziness, heartburn |
| Uncommon | Elevated liver enzymes, itching, rash, sweating increase, gastritis, constipation, flatulence |
| Rare but serious | Severe hepatotoxicity (including fulminant hepatitis, jaundice), gastrointestinal bleeding/perforation, severe skin reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis), anaphylaxis/angioedema, thrombocytopenia, acute renal failure/interstitial nephritis, hyperkalemia |
Patients should seek immediate medical attention for signs of liver injury (yellowing of eyes/skin, dark urine, unusual fatigue, persistent nausea), severe skin reaction, or signs of gastrointestinal bleeding (black stools, vomiting blood) while taking Nimesulide.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.